drugset / Trial / NCT00531323
TMC 125 Blood Levels Study
RandomizedParallel-groupOpen-label
Summary
The purpose of the study is to look at whether changing directly from one medication for HIV (efavirenz) to a new medication for HIV (TMC125) has any effect on the levels of TMC125 in the blood, compared to when TMC125 is taken without efavirenz having been taken immediately beforehand. The study aims to help the investigators understand whether it is safe to change directly from efavirenz to TMC125 (with no gap between the treatments) in patients who need these treatments. The study will investigate the blood levels of TMC125 when it is taken both once and twice a day.
Timeline
- Start
- 2007-09
- Primary completion
- —
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etravirine | Small molecule | 200 mg | — |
| Subject | Etravirine | Small molecule | 400 mg | — |